Related Experiment Video
Updated: Jun 11, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Mechanisms of hypokalemia-induced ventricular arrhythmogenicity
1Department of Biomedical Sciences, The Danish National Research Foundation Centre for Cardiac Arrhythmia, The Panum Institute, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark. osadchii@mail.ru
Insights
Hypokalemia, or low potassium, in cardiac patients significantly increases arrhythmia risk and mortality. This condition disrupts heart electrical activity, prolonging repolarization and slowing conduction, leading to life-threatening arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Biochemistry
Background:
- Hypokalemia is a frequent finding in cardiac patients, often linked to diuretic use or hormonal imbalances.
- It's an independent risk factor for reduced survival and increased sudden cardiac death in these patients.
Purpose of the Study:
- To elucidate the electrophysiological mechanisms underlying hypokalemia-induced cardiac arrhythmias.
- To understand how low potassium levels affect ventricular repolarization, conduction, and pacemaker activity.
Main Methods:
- Review of animal studies and cardiac electrophysiology principles.
- Analysis of ion channel function and action potential characteristics in hypokalemic states.
Main Results:
- Hypokalemia prolongs ventricular repolarization by inhibiting potassium currents, increasing early afterdepolarizations.
- It slows conduction due to hyperpolarization and elevated excitation thresholds.
- Abnormal pacemaker activity arises from altered diastolic depolarization and delayed afterdepolarizations.
Conclusions:
- Hypokalemia creates an arrhythmogenic substrate through spatial repolarization gradients, unidirectional block, and shortened refractoriness.
- The interaction of triggers like afterdepolarizations and this substrate facilitates re-entry and life-threatening tachyarrhythmias.
Abstract:
Hypokalemia is a common biochemical finding in cardiac patients and may represent a side effect of diuretic therapy or result from endogenous activation of renin-angiotensin system and high adrenergic tone. Hypokalemia is independent risk factor contributing to reduced survival of cardiac patients and increased incidence of arrhythmic death. Animal studies demonstrate that hypokalemia-induced arrhythmogenicity is attributed to prolonged ventricular repolarization, slowed conduction, and abnormal pacemaker activity. The prolongation of ventricular repolarization in hypokalemic setting is caused by inhibition of outward potassium currents and often associated with increased propensity for early afterdepolarizations. Slowed conduction is attributed to membrane hyperpolarization and increased excitation threshold. Abnormal pacemaker activity is attributed to increased slope of diastolic depolarization in Purkinje fibers, as well as delayed afterdepolarizations caused by Ca2+ overload secondary to inhibition of Na+--K+ pump and stimulation of the reverse mode of the Na+--Ca2+ exchange. Hypokalemia effect on repolarization is not uniform at distinct ventricular sites thereby contributing to amplified spatial repolarization gradients which promote unidirectional conduction block. In hypokalemic heart preparations, the prolongation of action potential may be associated with shortening of effective refractory period, thus increasing the propensity for ventricular re-excitation over late phase of repolarization. Shortened refractoriness and slowed conduction contribute to reduced excitation wavelength thereby facilitating re-entry. The interplay of triggering factors (early and delayed afterdepolarizations, oscillatory prepotentials in Purkinje fibers) and a favorable electrophysiological substrate (unidirectional conduction block, reduced excitation wavelength, increased critical interval for ventricular re-excitation) may account for the mechanism of life-threatening tachyarrhythmias in hypokalemic patients.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Electrophysiology of Normal Cardiac Rhythm
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

